Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Saccharomyces Boulardii on Indirect Hyperbilirubinemia

NCT01411761 is registered in ClinicalTrials.gov with Zekai Tahir Burak Women's Health Research and Education Hospital as lead sponsor.

NCT NCT01411761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Saccharomyces Boulardii on Indirect Hyperbilirubinemia
Lead sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2011
Completion date
December 31, 2011
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indirect hyperbilirubinemia